Efficacy of i-Factor Bone Graft versus Autograft in Anterior. i-FACTOR Peptide Enhanced Bone Graft Technology Platform i-FACTOR Bone. iFactor Mechanism of Action Step 2: ATTACH The high affinity between cells and P-15 supports the physiological mechanism of action in which cells bind. Kashuba commented to OTW, “The proceeds of the financing will be used to fund our two primary initiatives: Expanding upon our ongoing commercial success and helping to fund our IDE study in TLIF with the next generation version of our product.”Īsked what sort of growth they envision over the next 12 months, Kashuba told OTW, “While we prefer not to share revenue numbers publicly at this time, we’re currently much more than doubling our annual revenues and expect to be able to continue on this trajectory for some time. combination, bone graft substitutes may be utilized for many orthopaedic applications. Type of graft: synthetic Use: for orthopedic surgery Features: putty. This unique drug-device technology enhances the body's natural bone healing process through cellular activity that is directional and predictable. “We are fortunate to be supported by KCK Group, a partner that shares in the long-term vision that differentiated products that provide safety, efficacy and economic value, supported by human clinical results, will ultimately provide the highest value to surgeons and their patients."Īccording to the company, i-FACTOR Peptide Enhanced Bone Graft is based on proprietary biomimetic small peptide (P-15) technology that has a novel mechanism of action (attract, attach, and activate) that induces osteoblast cell proliferation and differentiation to accelerate new bone formation in patients with degenerative disc disease. We also understand the value of Level I human clinical data and are committed to investing and expanding our indications.” All of our physicians are board certified or board eligible. The result of ifactor is an object of domain type Factored. With educational backgrounds from some of the most prestigious medical schools in the nation, Peachtree Orthopedics physicians are widely known for their diverse expertise. "This year we have exceeded our own expectations regarding year-over-year revenue growth and have significantly expanded our user base as surgeons continue to express a high level of satisfaction with clinical results that support the safety and efficacy of our product. ifactor(n) computes the prime factorization n s p 1 e 1 p r e r of the integer n, where s is the sign of n, p 1,, p r are the distinct positive prime divisors of n, and e 1,, e r are positive integers.
Kashuba, chief executive officer of Cerapedics. "We are pleased to announce that we have successfully completed an equity financing that will continue to accelerate the commercial release of i-FACTOR Peptide Enhanced Bone Graft and support the execution of a second Level I investigational device exemption (IDE) human clinical study that will broaden our market indication in the $2 billion U.S. Cerapedics, based in Westminster, Colorado, has announced that the company has completed a $22 million financing led by KCK Group, a family investment fund.
0 kommentar(er)
